fbpx

David H. Van Thiel, M.D. has been honored by the Global Directory of Who's Who

Health Services Gastroenterology

Aug 09, 2022

Chicago, Illinois-

David H. Van Thiel, M.D., graduated with Honors from the University of California in Los, Angeles, completed residencies in internal medicine and subsequently gastroenterology and hepatology fellowships at Cornell University Hospital in New York City, Boston University in Boston Massachusetts, and the National Institutes of Health (Endocrinology and Health Human Services Branch) in Bethesda, Maryland. He has held Professorships in Medicine and Surgery at the University of Pittsburgh, Baptist Medical Center in Oklahoma City, Loyola University in Maywood, St. Luke's Hospital in Milwaukee Wisconsin, and Rush University Medical Center in Chicago.

Dr. David Van Theil's lifetime focus has been on all types of liver disease and their various complications as well as the appropriate timing for evaluation and subsequent liver transplantation. He is recognized as The Medical Father of Liver Transplantation in the United States. His principal current interest includes alcohol liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), primary biliary cirrhosis, chronic active liver disease and cirrhosis, metabolic liver diseases including alpha-1 antitrypsin deficiency, hemochromatosis, the carious porphyria's, Alagille disease, drug-induced liver disease, granulomatous liver disease, Wilson's disease, inborn errors of metabolism that affects the liver, Byler's disease, Familial Benign Recurrent Cholestasis, Polycystic liver disease, cirrhosis associated with Cystic Fibrosis, Caroli's disease, and other heritable liver diseases. 

Because of his interest in fatty liver disease and its various subtypes, his office is equipped with the most complete abdominal ultrasound equipment using the super Sonic (MACH 30 imaging system with Shear Wave Elastography and the MACH V4 software to quantify hepatic fibrosis, stiffness, and steatosis, characteristics required to appropriately classify individual subtypes of generic fatty liver disease. This equipment eliminates the need for liver biopsy in greater than 85% of cases. His office is 1 of the 5 facilities in the USA to have this equipment.

He has been recognized by the medical world as being a former President of the Midwest Society for Clinical Research, Association for the Study of Liver Disease in the United States, Fellowship in the European Association for the Study of Liver Disease, President of the Research Society for Alcoholism, as well more than 1334 peer-reviewed publications result in his recipient of the Marquis Award for a lifetime of excellence in medical publications. Importantly in 2022, he was recognized as the most frequently cited Author of Liver Disease Publications in the USA. 

 He is available for clinical evaluations Friday and Saturday from 2 PM to 7 PM as well as for essential urgent issues during the week beginning at 10 AM on a prescheduled basis.



About David H. Van Thiel M.D.

Endocrinology, Diabetes & Metabolism Gastroenterology, Hepatology, with over 55 years of experience; He has served as the chief of Gastroenterology/ Hepatology at the University of Pittsburgh

Name: David H. Van Thiel M.D.

Phone: (312) 573-1633

Related Links




View User Profile

Other Press Releases By David H. Van Thiel M.D.

David H. Van Thiel, M.D.
David H. Van Thiel, M.D. has been honored by the Global Directory of Who's Who